Basel Medical Group Ltd (BMGL)

NASDAQ: BMGL · Real-Time Price · USD

0.7060

+0.0262 (3.85%)

At close: Feb 18, 2026, 4:00 PM EST

0.6900

-0.0160 (-2.27%)

After-hours: Feb 18, 2026, 6:30 PM EST

Basel Medical Group Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Feb '26 Feb 18, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Market Capitalization	13	33	-	-	-
Enterprise Value	10	29	-	-	-
Last Close Price	0.71	1.78	-	-	-
PS Ratio	1.39	3.52	-	-	-
PB Ratio	3.47	8.75	-	-	-
P/TBV Ratio	3.47	8.76	-	-	-
EV/Sales Ratio	1.00	3.10	-	-	-
Debt / Equity Ratio	1.04	1.04	0.76	1.31	2.74
Debt / EBITDA Ratio	-	-	1.84	2.82	3.34
Debt / FCF Ratio	-	-	2.28	2.78	3.76
Net Debt / Equity Ratio	-0.97	-0.97	0.49	1.08	2.29
Net Debt / EBITDA Ratio	4.19	4.19	1.41	2.90	3.42
Net Debt / FCF Ratio	0.31	0.31	1.47	2.27	3.14
Asset Turnover	0.73	0.73	0.66	0.61	-
Inventory Turnover	39.81	39.81	70.66	67.92	-
Quick Ratio	1.15	1.15	0.55	0.63	0.63
Current Ratio	1.23	1.23	2.26	2.28	2.18
Return on Equity (ROE)	-194.56%	-194.56%	31.77%	38.79%	-
Return on Assets (ROA)	-4.67%	-4.67%	10.18%	7.77%	-
Return on Invested Capital (ROIC)	-977.21%	-21.82%	19.67%	14.21%	16.72%
Return on Capital Employed (ROCE)	-20.10%	-20.10%	28.20%	22.50%	25.50%
Earnings Yield	-71.57%	-28.39%	-	-	-
FCF Yield	-91.54%	-36.13%	-	-	-
Buyback Yield / Dilution	-15.60%	-15.60%	-	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q